Mandate

Vinge advises EQT on its EUR 890 million sale of Dellner Couplers to Wabtec

March 19, 2025 M&A

Vinge together with Milbank advises the EQT VIII fund (“EQT”) on its sale of Dellner Couplers (“Dellner”), a leading provider of train connection systems for passenger rail, to Wabtec Corporation (a fortune 500 company listed on the New York Stock Exchange, NYSE: WAB). The transaction values Dellner at approximately EUR 890 million. The transaction is subject to customary conditions and regulatory approvals.

Dellner Couplers is a global leader in train connection systems, providing safety-critical components and services to rail manufacturers and operators worldwide. Founded in 1941 in Vika, Sweden, the Company has grown from a family-owned business into one of the most trusted partners of the global rail industry with a strong presence across Europe, North America, and Asia. Its advanced product portfolio includes couplers, gangways, dampers, and aftermarket services, supporting reliable and efficient rail transportation. Dellner has 17 subsidiaries around the world and more than 1,200 employees globally.

EQT was advised by J.P. Morgan Securities Plc, Milbank, Vinge and EY.

Vinge's team primarily consisted of Christina Kokko, Samra Tesser, Linus Adolfsson and Ian Linde.

Read the clients press release here.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026